PAR DRUGS AND CHEMICALS
Back to Balance Sheet
|
PAR DRUGS AND CHEMICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹17 Cr | ₹12 Cr | ₹14 Cr | ₹15 Cr | ₹16 Cr |
What is the latest Total Current Liabilities ratio of PAR DRUGS AND CHEMICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹16 Cr |
How is Total Current Liabilities of PAR DRUGS AND CHEMICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 33.20 | |
| Mar2024 | ₹12 Cr | -11.08 | |
| Mar2023 | ₹14 Cr | -5.84 | |
| Mar2022 | ₹15 Cr | -7.02 | |
| Mar2021 | ₹16 Cr | - | |
Compare Total Current Liabilities of peers of PAR DRUGS AND CHEMICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PAR DRUGS AND CHEMICALS | ₹109.6 Cr | 3.1% | -2.2% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | 3.1% |
-2.2% |
-12.1% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses